BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS

被引：309

作者：

CASATI, S

PASSERINI, P

CAMPISE, MR

GRAZIANI, G

CESANA, B

PERISIC, M

PONTICELLI, C

机构：

[1] OSPED MAGGIORE POLICLIN, IST SCI MED, MILAN, ITALY

[2] CILAG LTD, CLIN RES & DEV, SCHAFFHAUSEN, SWITZERLAND

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1987年 / 295卷 / 6605期

关键词：

D O I：

10.1136/bmj.295.6605.1017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1017 / 1020

页数：4

共 17 条

[1] KIDNEY AND ERYTHROPOIESIS [J].

ADAMSON, JW ;

ESCHBACH, J ;

FINCH, CA .

AMERICAN JOURNAL OF MEDICINE, 1968, 44 (05) :725-+

[2]

[Anonymous], 1971, STAT PRINCIPLES EXPT

[3] HEMODYNAMICS OF UREMIC ANEMIA [J].

COLEMAN, TG .

CIRCULATION, 1972, 45 (02) :510-&

[4]

DIXON WJ, 1981, BMDP STATISTICAL SOF

[5]

Draper N.R, 1998, APPL REGRESSION ANAL, V326, DOI 10.1002/9781118625590

[6] DEVELOPMENT OF RADIOIMMUNOASSAYS FOR HUMAN ERYTHROPOIETIN USING RECOMBINANT ERYTHROPOIETIN AS TRACER AND IMMUNOGEN [J].

EGRIE, JC ;

COTES, PM ;

LANE, J ;

DAS, REG ;

TAM, RC .

JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 99 (02) :235-241

[7]

ELWOOD PC, 1974, LANCET, V1, P891

[8] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].

ESCHBACH, JW ;

EGRIE, JC ;

DOWNING, MR ;

BROWNE, JK ;

ADAMSON, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78

[9] AN EXTENSION OF BOXS RESULTS ON THE USE OF THE F DISTRIBUTION IN MULTIVARIATE-ANALYSIS [J].

GEISSER, S ;

GREENHOUSE, SW .

ANNALS OF MATHEMATICAL STATISTICS, 1958, 29 (03) :885-891

[10]

GORSKY JE, 1978, CLIN CHEM, V24, P1485

← 1 2 →